MD-X is a healthcare practice in Avelgem. Private Limited, started on 30 October 2018, 1 establishment.

What is the address of MD-X?

The registered office of MD-X is located at Raaptorfstraat 94, 8580 Avelgem.

Is MD-X still active?

Yes. According to the CBE (31 October 2026) MD-X is active, legal situation “Normale toestand”, started on 30 October 2018.

Is MD-X registered on Peppol?

Yes, MD-X is registered on the Peppol network with ID 0208:0712723534.

What is the enterprise number of MD-X?

The enterprise number of MD-X is BE0712723534.

When was MD-X founded?

MD-X was founded on 30 October 2018.

Who are the directors of MD-X?

According to the 2025 annual accounts, the directors of MD-X are: Jens Tack, Jana Hillaert.

Is MD-X a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 October 2018; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MD-X make in 2025?

MD-X posted a profit after taxes of € 56,402 in financial year 2025.

What is the revenue of MD-X?

As a small company, MD-X is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 80,601.

MD-X (Private Limited) - Avelgem - BE0712723534

Dossier MD-X, printed on 31 October 2026 from databakkes.be/en/0712723534/md-x. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MD-X from Avelgem, company number BE0712723534, closed financial year 2025 with a result of € 56,402 after tax. For that financial year MD-X recorded a gross margin of € 80,601 and equity of € 74,129. Compared with financial year 2024, the result moved from € 17,356 to € 56,402. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 74,129

▲ 281% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 56,402

▲ 225% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 22,505

▼ 42% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,720 paid out

3 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 53,836

▲ € 43,680 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 412

▲ 109% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,000

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 71,491 Gross margin 2022: € 71,491 First fiscal year in the series	€ 66,612 Gross margin 2023: € 66,612 ▼ 7% vs 2022 (€ 71,491) Unfavourable step	€ 34,785 Gross margin 2024: € 34,785 ▼ 48% vs 2023 (€ 66,612) Unfavourable step	€ 80,601 Gross margin 2025: € 80,601 ▲ 132% vs 2024 (€ 34,785) Favourable step	▲ 132%
Profit after taxes	€ 47,062 Profit after taxes 2022: € 47,062 First fiscal year in the series	€ 43,406 Profit after taxes 2023: € 43,406 ▼ 8% vs 2022 (€ 47,062) Unfavourable step	€ 17,356 Profit after taxes 2024: € 17,356 ▼ 60% vs 2023 (€ 43,406) Unfavourable step	€ 56,402 Profit after taxes 2025: € 56,402 ▲ 225% vs 2024 (€ 17,356) Favourable step	▲ 225%
Equity	€ 61,685 Equity 2022: € 61,685 First fiscal year in the series	€ 59,091 Equity 2023: € 59,091 ▼ 4% vs 2022 (€ 61,685) Unfavourable step	€ 19,447 Equity 2024: € 19,447 ▼ 67% vs 2023 (€ 59,091) Unfavourable step	€ 74,129 Equity 2025: € 74,129 ▲ 281% vs 2024 (€ 19,447) Favourable step	▲ 281%
Total debts	€ 50,804 Total debts 2022: € 50,804 First fiscal year in the series	€ 52,573 Total debts 2023: € 52,573 ▲ 3% vs 2022 (€ 50,804) Unfavourable step	€ 63,360 Total debts 2024: € 63,360 ▲ 21% vs 2023 (€ 52,573) Unfavourable step	€ 31,406 Total debts 2025: € 31,406 ▼ 50% vs 2024 (€ 63,360) Favourable step	▼ 50%
Cash	€ 22,931 Cash 2022: € 22,931 First fiscal year in the series	€ 43,165 Cash 2023: € 43,165 ▲ 88% vs 2022 (€ 22,931) Favourable step	€ 39,061 Cash 2024: € 39,061 ▼ 10% vs 2023 (€ 43,165) Unfavourable step	€ 22,505 Cash 2025: € 22,505 ▼ 42% vs 2024 (€ 39,061) Unfavourable step	▼ 42%
Retained profit	€ 43,085 Retained profit 2022: € 43,085 First fiscal year in the series	€ 40,491 Retained profit 2023: € 40,491 ▼ 6% vs 2022 (€ 43,085) Unfavourable step	€ 847 Retained profit 2024: € 847 ▼ 98% vs 2023 (€ 40,491) Unfavourable step	€ 55,529 Retained profit 2025: € 55,529 ▲ € 54,682 vs 2024 (€ 847) Favourable step	▲ € 54,682
Dividend	€ 122,000 Dividend 2022: € 122,000 First fiscal year in the series	€ 46,000 Dividend 2023: € 46,000 ▼ 62% vs 2022 (€ 122,000) Unchanged	€ 57,000 Dividend 2024: € 57,000 ▲ 24% vs 2023 (€ 46,000) Unchanged	€ 1,720 Dividend 2025: € 1,720 ▼ 97% vs 2024 (€ 57,000) Unchanged	▼ 97%
Balance sheet total	€ 112,489 Balance sheet total 2022: € 112,489 First fiscal year in the series	€ 111,664 Balance sheet total 2023: € 111,664 ▼ 1% vs 2022 (€ 112,489) Unchanged	€ 82,807 Balance sheet total 2024: € 82,807 ▼ 26% vs 2023 (€ 111,664) Unchanged	€ 105,535 Balance sheet total 2025: € 105,535 ▲ 27% vs 2024 (€ 82,807) Unchanged	▲ 27%

Key figures of MD-X, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MD-X?

What happened at MD-X in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 56,402 (▲ 225% vs 2024). filed late Source: NBB ↗
Oct 30, 2018 New establishment in Avelgem. KBO
2018 Jens Tack became a director. NBB
2018 Jana Hillaert became a director. NBB
Oct 30, 2018 Start of the company according to the CBE. KBO

In short

From € 47,062 profit in 2022 to € 56,402 profit in 2025.

Paid € 50,252 in corporate taxes since 2022.

Best year ever: 2025, with € 56,402 profit.

Paid out € 226,720 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jens Tack Jana Hillaert

MD-X

Behind MD-X are Jens Tack and Jana Hillaert.

Directors

According to the 2025 annual accounts

Jens Tack

Director

since 2018

Jana Hillaert

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Raaptorfstraat 94

8580 Avelgem

2.281.279.157

Stijn Streuvelslaan 7

8580 Avelgem

Active since 30 October 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0712.723.534

VAT number

BE 0712.723.534

Registered office

Raaptorfstraat 94, 8580 Avelgem

Names & denominations

MD-X

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 October 2018

Peppol

Active · Active since 28 Nov 2025

Activities · NACE

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

MD-X

Financials

What happened to MD-X?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions